Will New Covid Treatments Be as Elusive for Poor Countries ...
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain […]
Merck has taken a step to make its antiviral pill available in poor nations, but many obstacles remain […]
“It causes huge distress to tell a family, ‘We can’t serve you,’” said one state hospice organization director. […]
But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech […]
Published: October 14, 2021 at 05:57PM from NYT Health https://ift.tt/3BHYNnR
Rising immunity and modest changes in behavior may explain why cases are declining, but much remains unknown, scientists […]
The trend confirmed warnings that the coronavirus pandemic would undermine progress against other infectious diseases around the world. […]
People who have received the company’s one-shot vaccine may benefit from a booster with another brand. F.D.A. advisers […]
A U.S. panel is proposing a shift away from the use of low-dose aspirin in many people at […]
The agency said also said that it didn’t have enough time to independently review much of the raw […]
The new recommendations are aimed at food manufacturers and restaurants. Some experts say they don’t go far enough. […]